Krsnaa Diagnostics Ltd

Stage 4 · Declining · week 4

As of 20 Nov 2026, Krsnaa Diagnostics is in Stage 4, the downtrend phase, now in week 4 (since 23 Oct 2026). It closed at ₹519, 37.2% below its 52-week high and below its 200-day average, which is falling. In Health Care, 34.7% of stocks are in Stage 2.

Krsnaa Diagnostics Limited provides diagnostic services in India. More about the company

₹519.1
Close, 20 Nov 2026
+0.66% on the day
₹1,768 Cr · Small cap
Market DowntrendHealth Care 34.7% in Stage 2-11.4 pts / 20dHospitals & Diagnostic Centres 18.8%-3.1 pts

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

RS rank

Edge

—

KRSNAA is in a decline, 9% below its 200-day average. Declining stocks have lagged the market more than any other group; we wait for a base before looking again.

Its relative strength is 18 of 99, below the middle among NSE stocks over the past year. Hospitals & Diagnostic Centres ranks 15 of 106 industries by the strength of its stocks, among the leaders.

Is KRSNAA early, or has it already run? Pro answers that for every NSE stock, after every close.

Loading price chart…
Stage Cycle Timeline2023-08-24 → 2026-11-20
S2 26w
S2 24w
S4 17w
S4 33w
2023-08-242026-11-20
S1S2S3S4Setup score (0–10, dashed line at 5)
S3 2w → S2 26w → S3 7w → S4 10w → S1 6w → S2 24w → S3 8w → S4 17w → S1 6w → S2 6w → S3 12w → S4 33w → S1 8w → S4 4w current
Total tracked: 169 weeks across 14 stage runs.

KRSNAA among Hospitals & Diagnostic Centres23rd of 32 by relative strength

All 32 →
Stocks in Hospitals & Diagnostic Centres ranked by relative strength, with stage and one-month change
#StockStageRS1M
1KMCSHILStage 2 · wk 5498+35.8%
2VIJAYAStage 3 · wk 290+16.2%
3YATHARTHStage 2 · wk 2789+18.6%
4LALPATHLABStage 2 · wk 2383+9.3%
5APOLLOHOSPStage 3 · wk 782+21.1%
6MEDANTAStage 3 · wk 581+20.1%
7KIMSStage 4 · wk 178+18.0%
8METROPOLISStage 3 · wk 677+6.1%
…23KRSNAAStage 4 · wk 418+0.8%
vs 52W High
-37.2%
₹475 lo₹826.8 hi
37.2% below 52W high, deep Stage 4 damage
In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.
Stage Maturity
Week 4
1w13w26w
Week 4, early Stage 4 decline
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.
vs 200 DMA
-8.6%
200 DMA: ₹568.2 · sloping down
The stock is below its 200-day average, the mark of a downtrend. Stage analysis waits for the price to reclaim that line.
Rel Volume
0.16x
vs 50-day avg
Volume was well below average. Quiet sessions are common in a Stage 4 decline, and a low-volume bounce is easy to mistake for a reversal.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+0.8%
3M
-3.2%
6M
-7.8%
YTD
-28.0%
1Y
-36.2%
Sector
Health Care
↓ Peaking
Stage 2%
34.7%
20d Δ
-11.4pp
1M return
+11.5%
3M return
+3.8%
Sector Stage-2 % · last 20 days
Sector has 58 Stage 2 leaders. See Health Care Stage 2 →
Industry
Hospitals & Diagnostic Centres
↓ Peaking
Stage 2%
18.8%
20d Δ
-3.1pp
1M return
+17.6%
3M return
+0.9%
Industry Stage-2 % · last 20 days
Industry has 5 Stage 2 leaders. See Hospitals & Diagnostic Centres Stage 2 →

Mutual fund holdings

Held by 10 mutual funds in portfolios to October 2026: 6 active funds and 4 index funds and ETFs.

In October, among active funds: 1 reduced.

0 increased or opened1 reduced or exited
Largest active holders, by weight in the fund
All 10 funds and what each did in October

Mutual funds holding KRSNAA: the ten largest and the month’s moves →

Fund details on DiscoverMF

Scan Membership
Not in any scan now.
Last appeared 3 Sep 2025
Recent Stage Timeline
2026-11-20S4
Wk 4 · Vol 0.16x
2026-11-19S4
Wk 4 · Vol 0.15x
2026-11-18S4
Wk 4 · Vol 0.74x
2026-11-17S4
Wk 4 · Vol 1.88x
2026-11-16S4
Wk 4 · Vol 0.28x
2026-11-13S4
Wk 3 · Vol 1.48x
2026-11-12S4
Wk 3 · Vol 0.79x
2026-11-11S4
Wk 3 · Vol 0.47x
2026-11-09S4
Wk 3 · Vol 0.34x
2026-11-06S4
Wk 3 · Vol 0.41x
2026-11-05S4
Wk 2 · Vol 0.40x
2026-11-04S4
Wk 2 · Vol 0.44x
Moving averages & range
50 DMA
₹526.5
200 DMA
₹568.2
52W High
₹826.8
52W Low
₹475
5D Low
₹511.3
Resistance levels (recent highs)
20d High
₹528.8
60d High
₹565.6
120d High
₹575.3
250d High
₹821.5
Next resistance
+1.9%
to 20d High
P/E (TTM)
17.3
Forward 11.5
Earnings Growth (YoY)
+4.0%
Revenue +31.5%
ROE
+10.0%
Profit margin +11.1%
Dividend Yield
0.39%
P/B 1.6

Krsnaa Diagnostics: quick answers

What stage is Krsnaa Diagnostics in?

As of 20 Nov 2026, Krsnaa Diagnostics (KRSNAA) is in Stage 4, the downtrend phase. It entered Stage 4 on 23 Oct 2026 and is in week 4. What the four stages mean

Is Krsnaa Diagnostics in an uptrend?

No. Krsnaa Diagnostics is in a Stage 4 downtrend. It trades 8.6% below its 200-day average, which is falling.

How far is Krsnaa Diagnostics from its 52-week high?

Krsnaa Diagnostics closed at ₹519 on 20 Nov 2026, 37.2% below its 52-week high of ₹827. Its 52-week low is ₹475.

How has Krsnaa Diagnostics performed over the past year?

As of 20 Nov 2026, Krsnaa Diagnostics is down 36.2% over the past year and down 28.0% so far in 2026.

Which sector and industry is Krsnaa Diagnostics in?

Krsnaa Diagnostics is in the Hospitals & Diagnostic Centres industry, part of the Health Care sector. 61 stocks in Health Care are in Stage 2, 34.7% of the sector. See the Stage 2 stocks in Hospitals & Diagnostic Centres

About this companyHealth Care· Hospitals & Diagnostic Centres

Krsnaa Diagnostics Limited provides diagnostic services in India. It offers a range radiology services, including computed tomography scans, magnetic resonance imaging, X-rays, and ultrasound and advanced imaging; pathology services, such as laboratory, and home collection and preventive health; and teleradiology and telepathology services. The company also provides other diagnostics services, such as ophthalmic test, mammography, dental imaging, stress test, dual-energy X-ray absorptiometry scan, and bone mineral density test. It serves individual patients, government clients, corporate clients, hospitals, clinics, private practitioner, and other healthcare providers. Krsnaa Diagnostics Limited was incorporated in 2010 and is based in Pune, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-11-20. Past data patterns are not indicative of future results. This page is a data analytics tool only.